Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Digital Artery Pseudoaneurysm From Repetitive Compression While Gripping Toys.

Plastic and reconstructive surgery. Global open·2026
Same author

Utility of breath-hold half-Fourier single-shot turbo spin-echo with deep learning-based reconstruction for acquiring fat-suppressed T2-weighted images of the pancreas.

European journal of radiology open·2026
Same author

Eliminating Post-Operative Pain with Intercostal Nerve Cryoablation during Rib Cartilage Harvest for Total Microtia Construction.

Plastic and reconstructive surgery·2026
Same author

Response to Dr. S Dhanya Dedeepya' s letter.

Japanese journal of radiology·2026
Same author

Characterization and Management of a Rare Recurrent Pediatric Papillary Hemangioma.

Plastic and reconstructive surgery. Global open·2026
Same author

Identification of functional murine mitochondrial formyl peptides and their effects on myeloid-derived suppressor cell generation.

FEBS open bio·2026

Related Experiment Video

Updated: Jun 15, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

siRNA-based therapy ameliorates glomerulonephritis.

Hideki Shimizu1, Yuichi Hori, Shinya Kaname

  • 1Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Journal of the American Society of Nephrology : JASN
|March 6, 2010
PubMed
Summary

This study presents a novel nanocarrier system for targeted delivery of short interfering RNA (siRNA) to glomeruli, effectively silencing genes and improving kidney function in a glomerulonephritis mouse model.

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Related Experiment Videos

Last Updated: Jun 15, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Area of Science:

  • Nephrology
  • Nanomedicine
  • Molecular Biology

Background:

  • Short interfering RNA (siRNA) therapy shows therapeutic potential but faces challenges in in vivo delivery.
  • Targeted delivery of therapeutic molecules to the glomerulus is crucial for treating kidney diseases.

Purpose of the Study:

  • To develop a nanocarrier system for targeted siRNA delivery to glomeruli.
  • To evaluate the efficacy of this system in silencing intraglomerular genes and treating glomerulonephritis.

Main Methods:

  • Development of poly(ethylene glycol)-poly(l-lysine)-based nanocarriers for siRNA encapsulation.
  • Intraperitoneal administration of siRNA/nanocarrier complexes in a mouse model of glomerulonephritis.
  • Assessment of gene silencing, kidney function, proteinuria, and fibrotic markers.

Main Results:

  • siRNA/nanocarrier complexes (10-20 nm) achieved prolonged circulation and glomerular targeting.
  • Targeted suppression of mitogen-activated protein kinase 1 (MAPK1) mRNA and protein expression.
  • Significant improvement in kidney function, reduction in proteinuria, and amelioration of glomerular sclerosis.
  • Downregulation of profibrotic markers including TGF-beta1, PAI-1, and fibronectin.

Conclusions:

  • Successfully developed a nanocarrier system for effective intraglomerular gene silencing using siRNA.
  • This approach demonstrates potential for investigating renal disease mechanisms and offers a novel molecular therapy for glomerular diseases.